Detta är en gammal version av dokumentet!
Innehållsförteckning
Liver steatosis
Hepatic steatosis, also known as fatty liver disease, refers to abnormal accumulation of fat within hepatocytes, most commonly manifesting as non-alcoholic fatty liver disease (NAFLD).AJR Am J Roentgenol 2012
Epidemiology
Hepatic steatosis affects up to 30% of the general population in Western countries, with rising prevalence linked to obesity, diabetes, and metabolic syndrome.Radiology 2021 Prevalence exceeds 70% in patients with type 2 diabetes and reaches 90% in those undergoing bariatric surgery.
Clinical presentation
Most cases remain asymptomatic and are detected incidentally on ultrasound or other imaging.World J Gastroenterol 2014 Symptomatic patients may report right upper quadrant discomfort, fatigue, or elevated liver enzymes.
Pathology
Steatosis results from impaired fat metabolism, with triglycerides accumulating in >5% of hepatocytes.Eur J Radiol 2007 Macrovesicular steatosis predominates, featuring a single large cytoplasmic fat droplet displacing the nucleus.
Radiographic features
Ultrasonography
- Hyperechoic liver parenchyma (”bright liver”) compared to kidney or spleenRadioGraphics 2006
- Grading:
| Grade | Features |
|---|---|
| Mild | Slight echogenicity increase |
| Moderate | Impaired vessel wall visualization |
| Severe | Poor diaphragm/portal vein visibility |
Computed tomography
- Unenhanced CT: Liver attenuation <40 HU absolute or >10 HU lower than spleenAJR Am J Roentgenol 2012
- Contrast-enhanced: Focal sparing appears hyperdense relative to steatotic parenchyma (gallbladder fossa, segment IV)AJR Am J Roentgenol 2012
- Dual-energy CT improves quantificationRadiology 2021
Magnetic resonance imaging
- Chemical shift imaging (in/out-of-phase): Signal dropout on opposed-phase images (>5% fat)Radiology 2021
- Proton density fat fraction (PDFF): Gold standard for quantificationRadiology 2021
- Spectroscopy: Measures fat fraction directly
Treatment and prognosis
Management targets underlying causes (weight loss, diabetes control).World J Gastroenterol 2014 Steatosis alone carries excellent prognosis without fibrosis; NASH risks progression to cirrhosis (20-30%).
Differential diagnosis
- Glycogen storage disease (US: hyperechoic but vessels clear)RadioGraphics 2006
- Acute hepatitis (diffuse hypoechoic)Eur J Radiol 2007
- Focal fat sparing/deposition mimics massRadioGraphics 2006
- Iron overload (high attenuation on CT)AJR Am J Roentgenol 2012
Medical Disclaimer: Portions of this content were AI-generated to facilitate rapid knowledge synthesis. Radiologists and clinicians must independently verify all information against peer-reviewed literature, institutional protocols, and patient-specific factors before clinical application.
